Advanced Enzyme Valuation
| ADVENZYMES | 330.80 0.80 0.24% |
At this time, the firm appears to be overvalued. Advanced Enzyme Tech shows a prevailing Real Value of USD277.57 per share. The current price of the firm is USD330.8. Our model approximates the value of Advanced Enzyme Tech from analyzing the firm fundamentals such as Current Valuation of 31.54 B, return on equity of 0.0944, and Profit Margin of 0.20 % as well as examining its technical indicators and probability of bankruptcy.
Price Book 2.6111 | Enterprise Value 31.5 B | Enterprise Value Ebitda 13.4454 | Price Sales 5.538 | Forward PE 16.6667 |
Overvalued
Today
Please note that Advanced Enzyme's price fluctuation is very steady at this time. Calculation of the real value of Advanced Enzyme Tech is based on 3 months time horizon. Increasing Advanced Enzyme's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Advanced Enzyme is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Advanced Stock. However, Advanced Enzyme's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 330.8 | Real 277.57 | Hype 330.8 | Naive 323.8 |
The intrinsic value of Advanced Enzyme's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Advanced Enzyme's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Advanced Enzyme Technologies helps investors to forecast how Advanced stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Advanced Enzyme more accurately as focusing exclusively on Advanced Enzyme's fundamentals will not take into account other important factors: Advanced Enzyme Cash |
|
Advanced Enzyme Total Value Analysis
Advanced Enzyme Technologies is presently expected to have takeover price of 31.54 B with market capitalization of 37.01 B, debt of 393.5 M, and cash on hands of 667.5 M. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Advanced Enzyme fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
31.54 B | 37.01 B | 393.5 M | 667.5 M |
Advanced Enzyme Investor Information
About 56.0% of the company shares are held by company insiders. The book value of Advanced Enzyme was presently reported as 127.0. The company recorded earning per share (EPS) of 12.24. Advanced Enzyme Tech last dividend was issued on the 23rd of July 2025. The entity had 5:1 split on the 25th of May 2017. Based on the measurements of operating efficiency obtained from Advanced Enzyme's historical financial statements, Advanced Enzyme Technologies is not in a good financial situation at this time. It has a very high probability of going through financial hardship in November.| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Total Cash From Operating Activities | 963 M | 1.5 B |
|
| |||||
| Operating Income | 1.2 B | 1.6 B |
|
|
Advanced Enzyme Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Advanced Enzyme has an asset utilization ratio of 39.28 percent. This suggests that the Company is making USD0.39 for each dollar of assets. An increasing asset utilization means that Advanced Enzyme Technologies is more efficient with each dollar of assets it utilizes for everyday operations.Advanced Enzyme Ownership Allocation
Advanced Enzyme holds a total of 111.88 Million outstanding shares. Advanced Enzyme Technologies retains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.Advanced Enzyme Profitability Analysis
The company reported the revenue of 6.37 B. Net Income was 1.31 B with profit before overhead, payroll, taxes, and interest of 4.87 B.About Advanced Enzyme Valuation
Our relative valuation model uses a comparative analysis of Advanced Enzyme. We calculate exposure to Advanced Enzyme's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Advanced Enzyme's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | 3.1 B | 2.6 B |
Advanced Enzyme Quarterly Retained Earnings |
|
Additional Tools for Advanced Stock Analysis
When running Advanced Enzyme's price analysis, check to measure Advanced Enzyme's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Advanced Enzyme is operating at the current time. Most of Advanced Enzyme's value examination focuses on studying past and present price action to predict the probability of Advanced Enzyme's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Advanced Enzyme's price. Additionally, you may evaluate how the addition of Advanced Enzyme to your portfolios can decrease your overall portfolio volatility.